| # | Drug | Count |
|---|---|---|
| 0 | TENOFOVIR DISOPROXIL FUMARATE | 24 |
| 1 | LAMIVUDINE | 17 |
| 2 | TENOFOVIR ALAFENAMIDE | 15 |
| 3 | LAMIVUDINE ORAL | 14 |
| 4 | ENTECAVIR | 11 |
| 5 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 9 |
| 6 | CYCLOPHOSPHAMIDE | 8 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 8 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 8 |
| 9 | ENTECAVIR ANHYDROUS | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRAZIQUANTEL | 5 | 0.0165 |
| 1 | BULEVIRTIDE | 1 | 0.0104 |
| 2 | CAFFEINE, MAGNESIUM SALICYLATE | 1 | 0.0039 |
| 3 | ADEFOVIR DIPIVOXIL | 5 | 0.0039 |
| 4 | PAMABROM | 1 | 0.0027 |
| 5 | CASPOFUNGIN ACETATE | 2 | 0.0013 |
| 6 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 9 | 0.0010 |
| 7 | ENTECAVIR | 11 | 0.0009 |
| 8 | MARIBAVIR | 2 | 0.0008 |
| 9 | LAMIVUDINE | 17 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 5 | 0.0017 |
| 1 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 2 | 0.0008 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 25 | 0.0005 |
| 3 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 24 | 0.0002 |
| 5 | Protease Inhibitor [EPC] | 7 | 0.0002 |
| 6 | Melatonin Receptor Agonist [EPC] | 2 | 0.0002 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 7 | 0.0001 |
| 8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 9 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |